Evaluation of Pharmaceutical Companies

5 Pages Posted: 15 Feb 2012  

Andrea Saravalle

University of Urbino

Date Written: April 8, 2010

Abstract

The present work has not the task of developing a discussion of the main methods and criteria in evaluating the company, but wants to focus on the evaluation of pharmaceutical companies. from a difference in size of pharmaceutical companies, we will focus on issues such time period, intangible assets, research and development costs, royalty.

Keywords: evaluation, pharmaceutical, valutazione aziendale, patent, intangible

JEL Classification: G30

Suggested Citation

Saravalle, Andrea, Evaluation of Pharmaceutical Companies (April 8, 2010). Available at SSRN: https://ssrn.com/abstract=2004224 or http://dx.doi.org/10.2139/ssrn.2004224

Andrea Saravalle (Contact Author)

University of Urbino ( email )

Via Saffi 2
Urbino, Pesaro-Urbino 61029
Italy

Paper statistics

Downloads
185
Rank
133,113
Abstract Views
742